Heather Preston - 24 Jun 2021 Form 4 Insider Report for Karuna Therapeutics, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 24 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Jun 2021, 17:31:37 UTC
Prior SEC filing: 23 Jun 2021
Next SEC filing: 22 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Heather Preston

Key filing fact

Heather Preston filed Form 4 for Karuna Therapeutics, Inc. on 28 Jun 2021.

Key facts

This page summarizes Heather Preston's Form 4 filing for Karuna Therapeutics, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 28 Jun 2021, 17:31.

Change

Previous filing in this sequence was filed on 23 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KRTX transaction

Common Stock

Other

Transaction value
Shares: +184
Change %: +2.9%
Price
Shares after: 6,556
Date: 24 Jun 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a distribution of common stock of the Issuer to partners of a limited partnership and includes subsequent distributions by the general partner of the limited partnership.